Yüklüyor......
Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
INTRODUCTION: Prostate cancer is a leading cause of cancer death among men in the Western world. Early detection of prostate cancer has been shown to decrease mortality, but has limitations with low specificity leading to unnecessary biopsies and overdiagnosis of low-risk cancers. The STHLM3 trial h...
Kaydedildi:
| Yayımlandı: | BMJ Open |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6576112/ https://ncbi.nlm.nih.gov/pubmed/31201191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-027816 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|